IL2 and systemic lupus erythematosus: - Low-dose IL-2 for treatment of SLE(Charact-IL-2) (ClinicalTrials.gov Identifier:NCT03312335)- Low-dose IL-2 treatment in SLE (ClinicalTrials.govIdentifier: NCT02084238)Induction of regulatory T cells by low-doseIL-2 in autoimmune and inflammatory diseases(ClinicalTrials.gov Identifier: NCT01988506)